© Vifor Pharma Switzerland-based Vifor Pharma is acquiring Spain’s Sanifit Therapeutics...

Vifor Pharma Doubles Down on Kidney Disease with New Acquisitions – BioSpace

© Vifor Pharma Switzerland-based Vifor Pharma is acquiring Spain’s Sanifit Therapeutics and Switzerland’s Inositec. In the first deal, Vifor picks up Sanifit’s SNF472, a novel, first-in-class inhibitor of vascular calcification. The drug is being…

 

Read the full article here


-- END RSP MOD -->